Evaluation of Efficiency of Screening Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in Hospitals Where the Bacteria Are Increasingly Prevalent
この論文をさがす
説明
<jats:title>ABSTRACT</jats:title> <jats:p>The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime- and ceftazidime-clavulanic acid disks are stable at −20°C for 12 weeks.</jats:p>
収録刊行物
-
- Journal of Clinical Microbiology
-
Journal of Clinical Microbiology 39 3696-3699, 2001-10-01
American Society for Microbiology
- Tweet
キーワード
- Klebsiella Infections/epidemiology
- Cefotaxime
- Microbial Sensitivity Tests
- Ceftazidime
- beta-Lactamases
- beta-Lactamases/drug effects
- Drug Stability
- Escherichia coli/drug effects*
- Klebsiella Infections/microbiology
- Escherichia coli Infections/epidemiology
- Escherichia coli
- Prevalence
- Humans
- Escherichia coli/enzymology
- Anti-Bacterial Agents/pharmacology*
- Clavulanic Acid
- Escherichia coli Infections
- beta-Lactamases/biosynthesis*
- Microbial Sensitivity Tests/standards
- Klebsiella pneumoniae/drug effects*
- Clavulanic Acid/pharmacology
- Hospitals
- Anti-Bacterial Agents
- Klebsiella Infections
- Klebsiella pneumoniae
- Klebsiella pneumoniae/enzymology
- Cefotaxime/pharmacology
- Microbial Sensitivity Tests/methods
- Ceftazidime/pharmacology
- Escherichia coli Infections/microbiology